Live Webinar - Building a serialization blueprint: A roundtable on early-stage planning with 3PLs for successful commercialization

In the complex world of pharmaceuticals, serialization is more than a compliance requirement; it's a foundational element of secure, traceable, and efficient supply chain operations. This roundtable discussion explores the crucial role of third-party logistics providers (3PLs) in establishing a robust serialization strategy during the early stages of drug development and setting the stage for smooth commercialization.

This roundtable is an invaluable opportunity for those navigating the pre-commercialization phase to learn from industry veterans, foster partnerships, and lay the groundwork for successful commercialization. Attendees will leave with a comprehensive understanding of the strategic value 3PLs can bring to their serialization journey and a roadmap to commercial success.

On September 26, Arena International will invite experts from Krystal Biotech, Ferring Pharmaceuticals,
and AmerisourceBergen ICS to discuss:
     •  The role third-party logistics providers (3PLs) play in establishing a serialization strategy
     •  Lessons learned from pharma manufacturers who have begun and have established their serialization blueprint
     •  Best practices for forming early-stage 3PL partnerships

Panelists:
     •  Jeff Primeau, Vice President, Business Solutions, AmerisourceBergen ICS
     •  Ryan Majewski, Associate Director, US Commercial Supply Chain, Krystal Biotech, Inc
     •  Jeff Bragar, Senior Manager, Commercial Supply Chain, Ferring Pharmaceuticals, Inc.
     •  Tracie Sasaki, Director of Operations, AmerisourceBergen ICS Reno Distribution Center
     •  Kristy Dinh, Director, Applications Delivery, ICS Technology & Innovative Solutions
     •  Madison Leigh, Manager, Secure Supply Chain, AmerisourceBergen ICS